Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C P Alderman

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
The Annals of Pharmacotherapy|January 1, 1996
Adverse effects of the angiotensin-converting enzyme inhibitorsC P Alderman
The Australian and New Zealand Journal of Psychiatry|August 12, 1999
Liability in prescribing choice: a different perspectiveC P Alderman
The Annals of Pharmacotherapy|August 31, 1999
Possible interaction between nefazodone and pravastatinC P Alderman
Journal of Clinical Pharmacy and Therapeutics|February 1, 1997
A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unitC P Alderman
The Annals of Pharmacotherapy|February 1, 1996
Cefpodoxime proxetil for infective exacerbations of chronic obstructive airway diseaseC P Alderman
Drug Safety|February 15, 2000
Patient-oriented strategies for the prevention of drug interactionsC P Alderman
The Annals of Pharmacotherapy|January 17, 2002
Understanding antipsychotic drug tolerabilityC P Alderman
Journal of Quality in Clinical Practice|February 22, 2002
A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospitalC P Alderman, C Farmer
The Australian and New Zealand Journal of Psychiatry|April 10, 1999
Fluvoxamine-methadone interactionC P Alderman, P A Frith
The Medical Journal of Australia|July 3, 1995
Mini-mental state examination alone may not adequately rule out the possibility of cognitive deficitC P Alderman, P G Peters
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
The Annals of Pharmacotherapy|January 1, 1996
Adverse effects of the angiotensin-converting enzyme inhibitorsC P Alderman
The Australian and New Zealand Journal of Psychiatry|August 12, 1999
Liability in prescribing choice: a different perspectiveC P Alderman
The Annals of Pharmacotherapy|August 31, 1999
Possible interaction between nefazodone and pravastatinC P Alderman
Journal of Clinical Pharmacy and Therapeutics|February 1, 1997
A prospective analysis of clinical pharmacy interventions on an acute psychiatric inpatient unitC P Alderman
The Annals of Pharmacotherapy|February 1, 1996
Cefpodoxime proxetil for infective exacerbations of chronic obstructive airway diseaseC P Alderman
Drug Safety|February 15, 2000
Patient-oriented strategies for the prevention of drug interactionsC P Alderman
The Annals of Pharmacotherapy|January 17, 2002
Understanding antipsychotic drug tolerabilityC P Alderman
Journal of Quality in Clinical Practice|February 22, 2002
A brief analysis of clinical pharmacy interventions undertaken in an Australian teaching hospitalC P Alderman, C Farmer
The Australian and New Zealand Journal of Psychiatry|April 10, 1999
Fluvoxamine-methadone interactionC P Alderman, P A Frith
The Medical Journal of Australia|July 3, 1995
Mini-mental state examination alone may not adequately rule out the possibility of cognitive deficitC P Alderman, P G Peters
Pageof 4